Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Active not recruiting × Chondrosarcoma × regorafenib × Clear all

Phase

Status

Recruiting 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Colorectal Neoplasms 8 Sarcoma, Ewing 2 Osteosarcoma 2 Thyroid Neoplasms 1 Solid Malignant Tumors 1 Rectal Neoplasms 1 Neoplasm Metastasis 1 Esophageal Neoplasms 1 Colonic Neoplasms 1 Chondrosarcoma 1 Chondroma 1 Carcinoma, Hepatocellular 1 Carcinoma 1 Advanced Colorectal Cancer 1 Advanced Biliary Tract Cancer 1 Adenocarcinoma 1

Interventions

regorafenib 1 ivosidenib 1 durvalumab 1 Zoledronic Acid 1 Proton Therapy 1 Pharmacogenomic Testing 1 HhAntag691 1 Gemcitabine 1 Cisplatin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02389244 2025-09-16

REGOBONE

UNICANCER

Phase 2 Active not recruiting

Chondroma, Chondrosarcoma, Osteosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡